Alembic Pharmaceuticals Limited (NSE:APLLTD)
803.40
-10.90 (-1.34%)
Feb 21, 2025, 3:29 PM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 14,858 employees as of March 31, 2024. The number of employees increased by 265 or 1.82% compared to the previous year.
Employees
14,858
Change (1Y)
265
Growth (1Y)
1.82%
Revenue / Employee
4.32M INR
Profits / Employee
407.01K INR
Market Cap
157.92B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Alembic Pharmaceuticals News
- 5 weeks ago - Alembic Pharmaceuticals receives USFDA approval for Brexpiprazole tablets - Business Upturn
- 2 months ago - Alembic Pharmaceuticals shares surge nearly 3% on USFDA approval for Divalproex Sodium Capsules - Business Upturn
- 2 months ago - Alembic Pharmaceuticals secures USFDA approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg - Business Upturn
- 2 months ago - Alembic Pharmaceuticals completes ANVISA GMP Audit for API-II Facility in Brazil - Business Upturn
- 2 months ago - Alembic Pharmaceuticals receives tentative USFDA approval for olopatadine hydrochloride solution - Business Upturn
- 3 months ago - Alembic Pharma shares surged nearly 5% today - Business Upturn
- 3 months ago - Alembic Pharmaceuticals secures USFDA approval for Ivabradine tablets - Business Upturn
- 3 months ago - Alembic Pharmaceuticals gains USFDA final approval for Diltiazem Hydrochloride extended-release capsules - Business Upturn